Aptevo Therapeutics Inc. Increase (Decrease) in Deferred Revenue
Aptevo Therapeutics Inc. (APVO) reported Increase (Decrease) in Deferred Revenue of -$3.71 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-03-13
- Aptevo Therapeutics Inc. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was $0.00.
- Aptevo Therapeutics Inc. increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was -$4.24M, a 212100.00% decline year-over-year.
- Aptevo Therapeutics Inc. increase (decrease) in deferred revenue for the quarter ending 2017-06-30 was $560.00K.
- Aptevo Therapeutics Inc. increase (decrease) in deferred revenue for the quarter ending 2017-03-31 was -$27.00K.
- Aptevo Therapeutics Inc. increase (decrease) in deferred revenue for fiscal 2017 was -$3.71M.
- Aptevo Therapeutics Inc. increase (decrease) in deferred revenue for fiscal 2016 was -$3.45M, a 231.83% decline from fiscal 2015.
- Aptevo Therapeutics Inc. increase (decrease) in deferred revenue for fiscal 2015 was $2.62M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | -$4.24M derived: sum of 2 quarters · filed 2018-03-13 | -$3.68M derived: sum of 3 quarters · filed 2018-03-13 | -$3.71M 10-K · filed 2018-03-13 |
| 2017-09-30 | -$4.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$3.68M derived: sum of 2 quarters · filed 2017-11-13 | -$3.71M 10-Q · filed 2017-11-13 | -$3.74M derived: sum of 4 quarters · filed 2018-03-13 |
| 2017-06-30 | $560.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $533.00K 10-Q · filed 2017-08-10 | $504.00K derived: sum of 3 quarters · filed 2018-03-13 | $506.00K derived: sum of 4 quarters · filed 2018-03-13 |
| 2017-03-31 | -$27.00K 10-Q · filed 2017-05-12 | -$56.00K derived: sum of 2 quarters · filed 2018-03-13 | -$54.00K derived: sum of 3 quarters · filed 2018-03-13 | -$1.91M derived: sum of 4 quarters · filed 2018-03-13 |
| 2016-12-31 | -$29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | -$27.00K derived: sum of 2 quarters · filed 2018-03-13 | -$1.88M derived: sum of 3 quarters · filed 2018-03-13 | -$3.45M 10-K · filed 2018-03-13 |
| 2016-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$1.85M derived: sum of 2 quarters · filed 2017-11-13 | -$3.42M 10-Q · filed 2017-11-13 | -$2.77M derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | -$1.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$3.43M 10-Q · filed 2017-08-10 | -$2.77M derived: sum of 3 quarters · filed 2017-08-10 | -$1.19M derived: sum of 4 quarters · filed 2017-08-10 |
| 2016-03-31 | -$1.57M 10-Q · filed 2017-05-12 | -$923.00K derived: sum of 2 quarters · filed 2017-05-12 | $666.00K derived: sum of 3 quarters · filed 2017-05-12 | |
| 2015-12-31 | $652.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $2.24M derived: sum of 2 quarters · filed 2017-03-31 | $2.62M 10-K · filed 2017-03-31 | |
| 2015-09-30 | $1.59M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-11-14 | $1.97M 10-Q · filed 2016-11-14 | ||
| 2015-06-30 | $379.00K 10-Q/A · filed 2016-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |